doi: 10.1176/appi.ajp.162.5.977CrossRefGoogle Scholar Lau, T., Bigio, B., Zelli, D., McEwen, B
Clinical trial results have shown that Retatrutide, an experimental obesity drug emerging as a competitor to the blockbuster treatments Wegovy and Zepbound, not only reduces weight but is also effective in treating fatty liver, a condition where fat accumulates in the liver
Glycaemic management in diabetes: old and new approaches
SGLT2 use was also associated with a slower annual rate of decline in eGFR, regardless of GLP-1 use at baseline
This can result in conditions such as uveitis, dry eye disease, keratopathy, and episcleritis, all of which are treatable
Ahora, selecciono la dosis